Key result
Speckle tracking echocardiography detects early myocardial dysfunction missed by conventional parameters in resistant hypertension.
Why the study?
Resistant hypertension is a major contributor to cardiovascular diseases and mortality, but the potential benefits of STE for assessing cardiac remodeling in this population needed demonstration.
Does two-dimensional speckle tracking echocardiography improve the detection of early stage left ventricular dysfunction and myocardial fibrosis in patients with resistant hypertension?
Does two-dimensional speckle tracking echocardiography improve the detection of early stage left ventricular dysfunction and myocardial fibrosis in patients with resistant hypertension?
Speckle tracking echocardiography offers a sensitive, non-invasive method to detect early myocardial dysfunction and fibrosis in patients with resistant hypertension, providing additive prognostic value over conventional echocardiography.
Answers are grounded in this paper and cite their sources.
May support early detection in resistant hypertension; leaves open prospective outcome trials before clinical adoption.
PURPOSE OF REVIEW: Resistant hypertension (RH) is a major contributor to cardiovascular diseases and is associated with increased all-cause and cardiovascular mortality. Cardiac changes such as impaired left ventricular (LV) function, left ventricular hypertrophy (LVH), myocardial fibrosis, and enlarged left atrium (LA) are consequences of chronic exposure to an elevated blood pressure. The purpose of this review article is to demonstrate the potential benefits of using STE as a non-invasive imaging technique in the assessment of cardiac remodeling in patients with hypertension and specifically in uncontrolled and RH population. RECENT FINDINGS: It is well-recognized that conventional transthoracic echocardiography is a useful analytic imaging modality to evaluate hypertension-mediated organ damage (HMOD) and in a resistant hypertensive population. More recently two-dimensional speckle tracking echocardiography (STE) has been utilized to provide further risk assessment to this population. Recent data has shown that STE is a new promising echocardiographic marker to evaluate early stage LV dysfunction and myocardial fibrosis over conventional 2D parameters in patients with cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Alsharari et al. (2021) conducted a review in Resistant hypertension. Speckle tracking echocardiography (STE) vs. Conventional 2D echocardiography was evaluated. Speckle tracking echocardiography provides a sensitive, non-invasive method for detecting early regional and global myocardial dysfunction undetected by conventional parameters in resistant hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: